Showing results (11-20 of 88) with videos related to
Sort By:
Pageof 9
BMC Cancer|April 18, 2015
A phase II study of weekly irinotecan in patients with locally advanced or metastatic HER2- negative breast cancer and increased copy numbers of the topoisomerase 1 (TOP1) gene: a study protocolIben Kümler, Eva Balslev, Jan Stenvang, et al.Acta Oncologica (Stockholm, Sweden)|May 28, 2004
Angiotensin converting enzyme inhibitors for cancer treatment?Henriette Lindberg, Dorte Nielsen, Benny V Jensen, et al.Acta Oncologica (Stockholm, Sweden)|August 23, 2016
Early <sup>18</sup>F-FDG-PET/CT as a predictive marker for treatment response and survival in patients with metastatic colorectal cancer treated with irinotecan and cetuximabKristin Skougaard, Dorte Nielsen, Benny Vittrup Jensen, et al.Breast Cancer Research and Treatment|January 11, 2019
PD-L1 expression in breast cancer: expression in subtypes and prognostic significance: a systematic reviewElisabeth Specht Stovgaard, Anne Dyhl-Polk, Anne Roslind, et al.Acta Oncologica (Stockholm, Sweden)|June 15, 2007
Anthracycline-induced chronic cardiotoxicity and heart failureJon M Appel, Dorte Nielsen, Bo Zerahn, et al.Biomed Research International|September 5, 2015
Concordance of Hypermethylated DNA and the Tumor Markers CA 15-3, CEA, and TPA in Serum during Monitoring of Patients with Advanced Breast CancerSøren Kristiansen, Lars Mønster Jørgensen, Morten Høgh Hansen, et al.The Breast Journal|January 1, 2025
Targeted Treatment of Metastatic Triple-Negative Breast Cancer: A Systematic ReviewAnna Martha Hammershøi Madsen, Rikke Helene Løvendahl Eefsen, Dorte Nielsen, et al.Journal of Clinical Medicine|February 10, 2024
Carboplatin plus Paclitaxel in Combination with the Histone Deacetylate Inhibitor, Vorinostat, in Patients with Recurrent Platinum-Sensitive Ovarian CancerHanieh Meteran, Anja Ør Knudsen, Trine Lembrecht Jørgensen, et al.Breast Cancer Research and Treatment|June 14, 2005
Predictors of central nervous system metastasis in patients with metastatic breast cancer. A competing risk analysis of 579 patients treated with epirubicin-based chemotherapyMarianne Ryberg, Dorte Nielsen, Kell Osterlind, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|February 24, 2006
Serum YKL-40, a new prognostic biomarker in cancer patients?Julia S Johansen, Benny Vittrup Jensen, Anne Roslind, et al.Pageof 9